CNS Pharmaceuticals, Inc. (CNSP)
4.90
-0.22
(-4.30%)
USD |
NASDAQ |
May 28, 16:00
4.77
-0.13
(-2.65%)
After-Hours: 19:37
CNS Pharmaceuticals Total Liabilities (Quarterly) : 4.582M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 176.89M |
| Assertio Holdings, Inc. | 135.67M |
| Johnson & Johnson | 119.71B |
| Eli Lilly & Co. | 85.38B |
| Merck & Co., Inc. | 82.75B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.653M |
| Shareholders Equity (Quarterly) | 0.0707M |
| Debt to Equity Ratio | 3.287 |
| Current Ratio | 0.884 |
| Net Debt Paydown Yield | 0.97% |